|
AK3L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.421730E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.810000E-04 |
| Normal-vs-Stage2 |
4.40150000000639E-05 |
| Normal-vs-Stage3 |
1.019220E-04 |
| Normal-vs-Stage4 |
2.36929999999358E-05 |
| Stage1-vs-Stage2 |
3.711800E-02 |
| Stage1-vs-Stage3 |
8.471600E-02 |
| Stage1-vs-Stage4 |
1.224410E-02 |
| Stage2-vs-Stage3 |
4.355800E-01 |
| Stage2-vs-Stage4 |
9.943200E-01 |
| Stage3-vs-Stage4 |
3.513000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.955000E-04 |
| Normal-vs-AfricanAmerican |
2.38140000052844E-07 |
| Normal-vs-Asian |
1.076540E-03 |
| Caucasian-vs-AfricanAmerican |
3.66279999997055E-07 |
| Caucasian-vs-Asian |
6.736400E-01 |
| AfricanAmerican-vs-Asian |
1.235620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.58980000000342E-05 |
| Normal-vs-Female |
2.315200E-03 |
| Male-vs-Female |
3.52719999999751E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.185200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.046600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.448420E-04 |
| Normal-vs-Age(81-100Yrs) |
7.813700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.814400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.280800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.067600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.847800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.350800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.120400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.315100E-03 |
| Normal-vs-Grade 2 |
8.620700E-04 |
| Normal-vs-Grade 3 |
1.009930E-04 |
| Normal-vs-Grade 4 |
1.50549999999861E-05 |
| Grade 1-vs-Grade 2 |
9.551800E-01 |
| Grade 1-vs-Grade 3 |
4.389600E-01 |
| Grade 1-vs-Grade 4 |
9.374000E-02 |
| Grade 2-vs-Grade 3 |
4.110300E-02 |
| Grade 2-vs-Grade 4 |
1.237040E-03 |
| Grade 3-vs-Grade 4 |
8.437800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.581550E-02 |
| Normal-vs-ccB subtype |
3.07340000005318E-06 |
| ccA subtype-vs-ccB subtype |
9.27591337074318E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.206700E-04 |
| Normal-vs-N1 |
3.804200E-03 |
| N0-vs-N1 |
7.088600E-01 |
|
|
